Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Research Articles, Cellular/Molecular

GIRK Channel Activity in Dopamine Neurons of the Ventral Tegmental Area Bidirectionally Regulates Behavioral Sensitivity to Cocaine

Nora M. McCall, Ezequiel Marron Fernandez de Velasco and Kevin Wickman
Journal of Neuroscience 8 May 2019, 39 (19) 3600-3610; DOI: https://doi.org/10.1523/JNEUROSCI.3101-18.2019
Nora M. McCall
1Graduate Program in Neuroscience, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nora M. McCall
Ezequiel Marron Fernandez de Velasco
2Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ezequiel Marron Fernandez de Velasco
Kevin Wickman
2Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin Wickman
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Dopamine (DA) neurons of the VTA have been widely implicated in the cellular and behavioral responses to drugs of abuse. Inhibitory G protein signaling mediated by GABAB receptors (GABABRs) and D2 DA receptors (D2Rs) regulates the excitability of VTA DA neurons, DA neurotransmission, and behaviors modulated by DA. Most of the somatodendritic inhibitory effect of GABABR and D2R activation on DA neurons reflects the activation of G protein-gated inwardly rectifying K+ (GIRK) channels. Furthermore, GIRK-dependent signaling in VTA DA neurons can be weakened by exposure to psychostimulants and strengthened by phasic DA neuron firing. The objective of this study was to determine how the strength of GIRK channel activity in VTA DA neurons influences sensitivity to cocaine. We used a Cre-dependent viral strategy to overexpress the individual GIRK channel subunits in VTA DA neurons of male and female adult mice, leading to enhancement (GIRK2) or suppression (GIRK3) of GIRK channel activity. Overexpression of GIRK3 decreased somatodendritic GABABR- and D2R-dependent signaling and increased cocaine-induced locomotor activity, whereas overexpression of GIRK2 increased GABABR-dependent signaling and decreased cocaine-induced locomotion. Neither manipulation impacted anxiety- or depression-related behavior, despite the link between such behaviors and DA signaling. Together, these data show that behavioral sensitivity to cocaine in mice is inversely proportional to the strength of GIRK channel activity in VTA DA neurons and suggest that direct activators of the unique VTA DA neuron GIRK channel subtype (GIRK2/GIRK3 heteromer) could represent a promising therapeutic target for treatment of addiction.

SIGNIFICANCE STATEMENT Inhibitory G protein signaling in dopamine (DA) neurons, including that mediated by G protein-gated inwardly rectifying K+ (GIRK) channels, has been implicated in behavioral sensitivity to cocaine. Here, we used a viral approach to bidirectionally manipulate GIRK channel activity in DA neurons of the VTA. We found that decreasing GIRK channel activity in VTA DA neurons increased behavioral sensitivity to cocaine, whereas increasing GIRK channel activity decreased behavioral sensitivity to cocaine. These manipulations did not alter anxiety- or depression-related behaviors. These data highlight the unique GIRK channel subtype in VTA DA neurons as a possible therapeutic target for addiction.

  • D2 dopamine receptor
  • dopamine
  • G protein
  • GABAB
  • Kir3
  • VTA

Introduction

Dopamine (DA) neurons of the VTA are an integral part of the mesocorticolimbic system, a network of brain regions that mediates behavioral responses to reward and drugs of abuse, including cocaine (Juarez and Han, 2016). Cocaine inhibits membrane monoamine transporters, including the DA transporter (DAT) (Rocha, 2003; Hall et al., 2004). As a result, cocaine increases DA levels in brain regions receiving dopaminergic projections (e.g., NAc), and locally within the VTA (Di Chiara and Imperato, 1988; Aragona et al., 2008). Cocaine exposure engages inhibitory G protein signaling in VTA DA neurons, including that mediated by somatodendritic D2 DA autoreceptors (D2Rs) and GABAB receptors (GABABRs). Elevated VTA DA levels stimulate D2Rs (Brodie and Dunwiddie, 1990; Ford, 2014), whereas GABAergic inputs activate GABABRs on VTA DA neurons (Edwards et al., 2017). The direct inhibitory effect of D2R and GABABR activation on VTA DA neurons is mediated largely by activation of G protein-gated inwardly rectifying K+ (GIRK/Kir3) channels (Cruz et al., 2004; Labouèbe et al., 2007; Arora et al., 2010). Whereas most neuronal GIRK channels contain GIRK1 and GIRK2 subunits (Luján et al., 2014), VTA DA neurons express a GIRK2/GIRK3 heteromeric channel (Cruz et al., 2004).

Work with knockout mice suggests that behavioral sensitivity to cocaine is inversely proportional to the strength of GIRK-dependent signaling in DA neurons. Girk2−/− mice exhibit increased locomotor responses to cocaine and morphine (Arora et al., 2010; Kotecki et al., 2015) and altered cocaine self-administration (Morgan et al., 2003), as do mice lacking GIRK channels in DA neurons (DATCre(+):Girk2fl/fl mice) (Kotecki et al., 2015; McCall et al., 2017). However, Girk2−/− mice exhibit an array of other behavioral phenotypes (Signorini et al., 1997; Blednov et al., 2001, 2003; Marker et al., 2004, 2005; Costa et al., 2005; Pravetoni and Wickman, 2008), as well as adaptations in excitatory and inhibitory neurotransmission in multiple reward-associated neuron populations (Arora et al., 2010; Hearing et al., 2013), making it challenging to attribute changes in cocaine-related behavior to a specific population. While DATCre(+):Girk2fl/fl mice afford increased cell specificity over Girk2−/− mice, GIRK-dependent signaling in all DA neurons, including those in the VTA, substantia nigra, and hypothalamus (Meister and Elde, 1993; Lorang et al., 1994; Demaria et al., 2000), is likely altered in this model.

Suppression of inhibitory G protein signaling in the VTA by pertussis toxin enhances the behavioral effects of cocaine (Steketee and Kalivas, 1991), suggesting that this signaling tempers behavioral sensitivity to cocaine. Notably, GIRK-dependent signaling in VTA DA neurons following psychostimulant exposure is decreased through channel internalization (Arora et al., 2011; Munoz et al., 2016). The strength of GIRK channel activity in VTA DA neurons is also modulated by neuronal excitability, with large depolarization events (e.g., phasic DA neuron firing) potentiating GIRK-dependent signaling, and hyperpolarization or tonic DA neuron firing reducing GIRK-dependent signaling (Lalive et al., 2014). These observations converge on a working model wherein in vivo psychostimulant exposure inhibits DA neurons via GABABR and D2R activation, leading to decreased strength of inhibitory G protein signaling mediated by GIRK channel activation and, consequently, increased behavioral sensitivity to cocaine (Hearing et al., 2012; Marron Fernandez de Velasco et al., 2015; Rifkin et al., 2017).

Here, we used viral and genetic approaches to determine how the strength of GIRK channel activity in VTA DA neurons influences behavioral sensitivity to cocaine in mice. Because VTA DA neurons project to a number of brain regions implicated in anxiety and depression, including the hippocampus, amygdala, and PFC, and activation of DA receptors in these brain regions influences anxiety- and depression-like behaviors (Zarrindast and Khakpai, 2015; Belujon and Grace, 2017), we also asked whether manipulation of GIRK channel activity in VTA DA neurons impacted negative affective behavior. We found that, while anxiety and depression-related behaviors were unaltered by our manipulations, behavioral sensitivity to cocaine was inversely related to the strength of GIRK-dependent signaling in VTA DA neurons.

Materials and Methods

Mice.

All studies were approved by the Institutional Animal Care and Use Committee at the University of Minnesota. B6.SJL-Slc6a3tm1.1(cre)Bkmn/J (stock #006660, The Jackson Laboratory, RRID:IMSR_JAX:006660), hereafter referred to as DATCre(+) mice, heterozygous for Cre, were used in all viral manipulation studies. This DATCre line has been widely used for the selective viral manipulation of DA neurons, offers improved selective targeting of dopaminergic over other available DA neuron-targeting Cre lines, and does not exhibit altered DAT expression in heterozygotes (Bäckman et al., 2006; Lammel et al., 2015; Stuber et al., 2015). The generation of DATCre:Girk2fl/fl mice was described previously (Kotecki et al., 2015). All mice for this study were bred in-house. Male and female mice were used for all studies, with groups balanced by sex. All mice were maintained on a 12 h light/dark cycle, and were provided ad libitum access to food and water.

Reagents.

Baclofen, CGP54626, quinpirole, sulpiride, Triton-X, and DPX were purchased from Sigma-Aldrich. Cocaine was obtained through Boynton Health Pharmacy at the University of Minnesota. Saline (0.9%) was purchased from Baxter Healthcare. Normal donkey serum was purchased from Gemini Bio-Products. The anti-TH antibody, made in sheep, was purchased from PelFreez (catalog #P60101-0, RRID:AB_461070); and the anti-GFP antibody, made in chicken, was purchased from Abcam (catalog #ab13970, RRID:AB_300798). Donkey anti-sheep Cy5 (catalog #703-225-155, RRID:AB_2340370) and donkey anti-chicken Cy2 (catalog #713-175-147, RRID:AB_2340730) secondary antibodies were purchased from Jackson ImmunoResearch Laboratories. All viruses were produced by the University of Minnesota Viral Vector and Cloning Core (Minneapolis). AAV8-DIO-hSyn-GIRK2c-IRES-GFP and AAV8-DIO-hSyn-GIRK3-IRES-GFP vectors were used to overexpress GIRK2 and GIRK3, respectively, in a Cre-dependent manner. Cre-dependent viruses expressing GFP (AAV8-DIO-hSyn-GFP) or mCherry (AAV8-DIO-hSyn-mCherry) served as controls.

Intracranial viral manipulations.

Mice (≥45 d) were placed in a stereotaxic frame (David Kopf Instruments) under isoflurane anesthesia. Microinjectors, made by affixing a 33-gauge stainless-steel hypodermic tube within a shorter 26-gauge stainless-steel hypodermic tube, were attached to polyethylene-20 tubing affixed to 10 μl Hamilton syringes, and were lowered through burr holes in the skull to the VTA (from bregma: −2.6 mm anteroposterior, ±0.6–0.7 mm mediolateral, −4.7 mm dorsoventral); 500 nl (2.16 × 1013 to 3.26 × 1014 genocopies/ml) of virus per side was injected over 5 min. Microinjectors were left in place for 10 min following infusion to reduce solution backflow along the infusion track. Immunohistochemistry, slice electrophysiology, and behavioral experiments were performed 3 weeks after surgery to allow for full recovery and viral expression.

Immunohistochemistry.

Mice were anesthetized with ketamine/xylazine and transcardially perfused with PB, followed by 4% PFA in 0.1 m PB. Brains were extracted and postfixed overnight in 4% PFA in PB at 4°C. Brains were then rinsed with PB and transferred to 30% sucrose in PB. Horizontal slices of VTA (50 μm) were prepared using a sliding microtome (SM 2000R, Leica Microsystems) and stored in PB at 4°C. Three slices, separated by ∼350 μm, were stained for each mouse; 3 separate mice per viral condition were analyzed. All steps were performed at room temperature, with free-floating slices, in a 24-well plate on a rocker. Slices were rinsed in PBS (3 × 10 min) and incubated in blocking solution (0.3% Triton-X and 3% normal donkey serum in PBS) for 2 h. Slices were then incubated overnight in blocking solution containing a sheep anti-TH antibody (1:500) and chicken anti-GFP antibody (1:500). Slides were rinsed with PBS (3 × 10 min) and then incubated in secondary antibodies diluted in PBS (1:500 donkey anti-sheep Cy5; 1:200 donkey anti-chicken Cy2) for 2 h, after which slices were rinsed with PBS (6 × 10 min). Slices were mounted on glass slides and allowed to fully dry before being dehydrated with 3 min incubations in: 70% EtOH, 80% EtOH, 95% EtOH, 100% EtOH, and xylene. Slides were mounted using DPX and allowed to dry. Slides were imaged by the University Imaging Center at the University of Minnesota on an A1R confocal microscope (Nikon) imaged with the Galvano scanner using 488 nm and 567 nm lines and filters. The images were collected using a 10×, 0.45 NA plan Apo objective at 1024 × 1024 pixels, with a zoom of 1× using the Scan Large Area feature using Perfect Focus. Four 15 μm z steps were collected, and images were generated in Nis-Elements AR (Nikon) using Extended Depth of Focus. To assess the fidelity and penetrance of the viruses, the Cy2 and Cy5 channels were merged using Fiji (https://imagej.nih.gov/ij/), with Cy2 as green and Cy5 as magenta. In the region of viral expression with in the VTA, the number of Cy2+ neurons, Cy5+ neurons, and Cy2+/Cy5+ neurons were quantified using the cell counter plugin in Fiji. Representative images in Figure 1 were taken with an IX81ZDC2 Olympus microscope at 20×.

Slice electrophysiology.

Somatodendritic currents were evaluated in both behaviorally naive mice (3 weeks following viral injection; 66–73 d) and at the conclusion of behavioral testing (5–6 weeks following viral injection; 80–110 d). Horizontal slices (225 μm) containing the VTA were prepared in ice-cold sucrose ACSF, as described previously (Kotecki et al., 2015; McCall et al., 2017). Neurons medial to the medial terminal nucleus of the accessory optic tract (MT), and identified via Cre-dependent viral-mediated fluorescence, were targeted for analysis. Whole-cell data were acquired using a Multiclamp 700A amplifier and pCLAMP version 9.2 software (Molecular Devices). Ih amplitude was assessed using a 1 s voltage ramp (−60 to −120 mV). Spontaneous activity was measured in current-clamp mode (I = 0) for 1 min. For rheobase assessments, cells were held in current-clamp mode and given 1 s current pulses, beginning at −80 pA and progressing in 20 pA increments until spiking was elicited. Rheobase was defined as the minimum current step evoking one or more action potentials. Agonist-induced somatodendritic currents were measured at a holding potential (Vhold) of −60 mV. All command potentials factored in a junction potential of −15 mV predicted using JPCalc software (Molecular Devices). Series and membrane resistances were tracked throughout the experiment. If series resistance was unstable, the experiment was excluded from analysis.

Behavior.

All mice in this study were evaluated in elevated plus maze (EPM), forced swim test (FST), and open field cocaine-induced locomotor activity assays in the light cycle, in this order, with at least 1 d separating each test. For the EPM test, mice were transferred to the testing room 1 h before evaluation. Mice were placed in the middle of the maze, facing a corner between an open and closed arm. Video was recorded using ANY-Maze Maze 5.2 (Stoelting) software and a STC-TB83USB-AS camera (Sensor Technologies America). Mice were allowed to freely explore the maze for 5 min. Between tests, the maze was wiped down with 70% EtOH. Time in arms, number of arm entries, and total distance traveled were analyzed using ANY-Maze software. For the FST study, mice were transferred to the testing room 1 h before evaluation. Mice were placed in a 4 L beaker filled with ∼1.5 L of 23°C water, for 6 min. Video was recorded using ANY-Maze software and a C615 camera (Logitech), and the latency to first immobile bout and total immobility time during the final 4 min of testing were analyzed by hand using ANY-Maze software. Cocaine-induced activity was assessed in open field activity chambers (Med Associates), as described previously (Pravetoni and Wickman, 2008). In brief, subjects were acclimated over 3 d, during which the animals were handled on 1 d and exposed to intraperitoneal injection (saline) on 2 d, and then placed in the open field. Distance traveled during the 60 min period following saline injection on the last acclimation day was taken as baseline activity. Cocaine-induced activity was then assessed following administration of three cocaine doses (3, 15, and 30 mg/ kg i.p.), with each dose separated by 3 d, as described previously (Kotecki et al., 2015).

Viral targeting accuracy was assessed in all subjects using fluorescence microscopy before post hoc slice electrophysiology experiments. To assess and summarize the expression pattern and spread of virus, 2× images of brightfield and fluorescent viral expression were taken with an IX81ZDC2 Olympus microscope, overlaid, and matched to figures in the horizontal atlas of the mouse brain (Franklin and Paxinos, 2008), and spread patterns were summarized. The pattern of viral spread for each mouse was overlaid on a simplified version of the atlas, with each spread pattern at 10% transparency to provide a sense of viral spread for individual subjects, and cumulatively for the study. Only data from mice in which the majority (>80%) of expression was confined to the VTA, with limited or no diffusion to adjacent structures (i.e., SN pars compacta), were analyzed in behavioral studies.

Experimental design and statistical analyses.

Data are presented throughout as mean ± SEM. Statistical analyses were performed using Prism 5 (GraphPad Software) and SigmaPlot 11.0 (Systat Software). All studies involved balanced groups of male and female mice. Data were analyzed first for effects of sex and viral condition, or sex and genotype, using two-way ANOVA when those were the only variables. For cocaine locomotor activity data with multiple testing days, the interaction of sex for each virus or genotype group was assessed using two-way repeated-measures ANOVA. When there was no effect of sex, male and female data were pooled. When there was an effect of sex or an interaction of sex with another factor, male and female data were analyzed and presented separately. Data were analyzed by t test, Mann–Whitney U test, two-way ANOVA, or repeated-measures ANOVA, with Bonferroni or post hoc tests, as appropriate. Differences were considered significant if p < 0.05.

Results

Viral manipulation of GIRK channel activity in VTA DA neurons

To manipulate the strength of GIRK channel activity in VTA DA neurons, we used a Cre-dependent viral strategy to overexpress GIRK2 or GIRK3 in adult DATCre(+) mice. We predicted that the overexpression of GIRK2 in VTA DA neurons would enhance GIRK channel activity, as GIRK2 can form functional homomeric channels and mediates the forward trafficking of GIRK channels (Lesage et al., 1995; Ma et al., 2002). Conversely, we predicted that the overexpression of GIRK3 would suppress GIRK channel activity, as GIRK3 is unable to form functional homomeric channels, it harbors a lysosomal targeting sequence that can promote GIRK channel internalization, and its presence correlates with decreased sensitivity of the VTA DA GIRK channel to GABABR-induced activation (Lesage et al., 1995; Ma et al., 2002; Labouèbe et al., 2007; Lunn et al., 2007).

We infused Cre-dependent control, GIRK2, or GIRK3 expression vectors into the VTA of DATCre(+) mice (Fig. 1A). Following viral infusion (3 weeks), we performed immunohistochemistry with horizontal sections containing the VTA, to assess the fidelity of our viral manipulations (Fig. 1B–E). Similar to published reports involving DATCre(+) mice (Lammel et al., 2015), we found that the vast majority of GFP-positive neurons examined in slices from mice treated with control (96%), GIRK2 (93%), or GIRK3 (92%) vectors expressed TH (TH+; Fig. 1C–E). Moreover, 75% of TH+ neurons in the region of viral expression were also GFP+, as measured in sections from DATCre(+) mice treated with control vector. Thus, our approach yielded a selective manipulation of VTA DA neurons in adult mice.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Viral overexpression of GIRK channel subunits in VTA DA neurons. A, DATCre(+) mice were given intra-VTA infusion of Cre-dependent control, GIRK2, or GIRK3 vector. Following viral injection (3 w), mice were processed for either immunohistochemistry or slice electrophysiology. B, Control virus expression in the VTA of DATCre(+) mice. In the region of viral infusion, the percentage of GFP+ neurons that were also dopaminergic (TH+) was calculated to determine viral fidelity in control (C), GIRK2 (D), and GIRK3 (E) viral conditions. F, The overexpression of GIRK2 (n = 7 cells from 3 mice, 547 ± 111 pA) enhanced GABABR currents compared with cells expressing a control virus (n = 6 cells from 2 mice, 238 ± 24 pA; Mann–Whitney U test, U = 6, p = 0.035). G, The overexpression of GIRK3 (n = 8 cells from 5 mice, 33 ± 7 pA) diminished GABABR currents compared with cells expressing a control virus (n = 4 cells from 3 mice, 255 ± 44 pA; Mann–Whitney U test, U = 0, p = 0.004). *p < 0.05. **p < 0.01.

To assess the functional consequences of overexpressing GIRK2 or GIRK3 in VTA DA neurons, we measured somatodendritic currents in acutely isolated brain slices evoked by a maximal concentration of the GABABR agonist baclofen (200 μm), as GIRK channels mediate ∼80% of this inhibitory current in VTA DA neurons (Labouèbe et al., 2007; Arora et al., 2010; Kotecki et al., 2015). As predicted, overexpression of GIRK2 in VTA DA neurons yielded enhanced GABABR-dependent currents compared with currents from control VTA DA neurons (Fig. 1F). Overexpression of GIRK2 did not, however, yield significant differences in apparent capacitance, membrane resistance, Ih, or spontaneous activity (Table 1). There was a significant increase in rheobase (Table 1), however, suggesting that GIRK2 overexpression decreased baseline neuronal excitability. Conversely, GIRK3 overexpression in VTA DA neurons suppressed GABABR-dependent currents (Fig. 1G). There were no significant differences in apparent capacitance, membrane resistance, Ih, rheobase, or spontaneous activity following GIRK3 overexpression (Table 1). Thus, the overexpression of GIRK2 or GIRK3 in VTA DA neurons bidirectionally alters the strength of GIRK-dependent signaling.

View this table:
  • View inline
  • View popup
Table 1.

Baseline electrophysiological parameters for neurons in Figure 1

Negative affective behaviors and cocaine sensitivity in DATCre:Girk2fl/fl mice

Previously, we reported that the genetic ablation of Girk2 in DA neurons correlated with an increased acute locomotor response to cocaine (McCall et al., 2017). Intriguingly, the excitability of VTA DA neurons has also been shown to influence negative affective behavior (Anstrom and Woodward, 2005; Nestler and Carlezon, 2006; Krishnan et al., 2007; Cao et al., 2010; Chaudhury et al., 2013; Russo and Nestler, 2013; Tye et al., 2013; Polter and Kauer, 2014). Thus, we sought to assess how manipulation of GIRK channel activity in VTA DA neurons altered performance in anxiety (EPM), depression (FST), and cocaine-induced motor activity tests (Fig. 2A). Because this behavioral battery approach had not been previously used by our laboratory, we evaluated DATCre(+):Girk2fl/fl and DATCre(−):Girk2fl/fl mice before testing the impact of VTA DA neuron-specific GIRK channel manipulations.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Negative affective and cocaine locomotor behavior in DATCre(+):Girk2fl/fl mice. A, Adult male and female DATCre(−):Girk2fl/fl and DATCre(+):Girk2fl/fl mice were tested in EPM, FST, and cocaine locomotor activity tests, with each task separated by at least 1 d. B, Percent time in open arms in the EPM is not different in Cre− (n = 18, 24 ± 4%) and Cre+ (n = 20, 31 ± 4%; Mann–Whitney U test, U = 132, p = 0.165). C, Time immobile for Cre− (n = 18, 160 ± 6 s) and Cre+ (n = 20, 145 ± 8 s) mice in the FST does not differ (t test, t(36) = 1.499, p = 0.143). D, Latency to immobility in male Cre+ (n = 10, 68 ± 11 s) mice is greater than in Cre− mice (n = 9, 39 ± 7 s; t test, t(17) = 2.210, p = 0.041), while there is no difference in latency to immobility between Cre− (n = 9, 80 ± 9 s) and Cre+ (n = 10, 98 ± 11 s; t test, t(17) = 1.213, p = 0.242) mice. E, There is no significant difference in distance moved on the handling habituation day between male Cre− (n = 9, 77 ± 4 m/h) and Cre+ (n = 10, 90 ± 6 m/h; t test, t(17) = 1.774, p = 0.094) mice. However, female Cre+ mice (n = 10, 110 ± 8 m/h) moved significantly more than Cre− mice (n = 9, 75 ± 4m/h; t test, t(17) = 3.876, p = 0.001). F, In male and female mice, distance traveled following injection of 0, 3, 15, and 30 mg/kg cocaine resulted in an interaction between cocaine dose and genotype (males, two-way repeated-measures ANOVA, interaction between cocaine dose and virus, F(3,51) = 13.557, p < 0.001; females, two-way repeated-measures ANOVA, interaction between cocaine dose and virus, F(3,51) = 3.213, p = 0.030). Male Cre+ mice moved significantly more than Cre− mice at 15 mg/kg (Bonferroni post hoc test, t = 5.863, p < 0.001) and 30 mg/kg (Bonferroni post hoc test, t = 6.907, p < 0.001) cocaine. Similarly, female Cre+ mice moved significantly more than Cre− mice at 15 mg/kg (Bonferroni post hoc test, t = 4.249, p < 0.001) and 30 mg/kg (Bonferroni post hoc test, t = 2.809, p = 0.006) cocaine. *p < 0.05. **p < 0.01. ***p < 0.001.

DATCre(+):Girk2fl/fl mice exhibited similar percent time in open arms of the EPM compared with DATCre(−):Girk2fl/fl mice (Fig. 2B), and there were no genotype differences in percent time spent in closed arms (Cre−, 63 ± 3%; Cre+, 59 ± 4%, t test, t(36) = 0.820, p = 0.418), number of entries into open arms (Cre−, 10 ± 1 entries; Cre+, 10 ± 1 entries, Mann–Whitney test, U = 150.5, p = 0.393), and number of entries into closed arms (Cre−, 11 ± 1 entries; Cre+, 11 ± 1 entries; t test, t(36) = 0.7710, p = 0.446). Thus, loss of GIRK channel activity in DA neurons does not appear to influence anxiety-like behavior.

In the FST, we did not observe a difference in time immobile for DATCre(−):Girk2fl/fl mice and DATCre(+):Girk2fl/fl mice (Fig. 2C). We did observe a main effect of sex in the latency to immobility measure (ANOVA, F(1,34) = 12.67, p = 0.001), however; and as such, these data were analyzed separately by sex (Fig. 2D). While female mice did not display an effect of genotype on latency to immobility (Fig. 2D), male DATCre(+):Girk2fl/fl mice exhibited a longer latency than male DATCre(−):Girk2fl/fl mice, suggesting an antidepressive behavioral phenotype. Notably, the reduced time to immobility in male DATCre(+):Girk2fl/fl mice (Fig. 2D) is consistent with a previous report, which found that male Cre+ mice from a separately developed DATCre:Girk2fl/fl mouse line displayed an antidepressive behavioral phenotype (Honda et al., 2018). Thus, GIRK channel activity in DA neurons appears to enhance depression-related behavior in male mice.

Finally, we assessed cocaine-induced motor activity in DATCre(+):Girk2fl/fl mice (Fig. 2A,E). Similar to our previous study (McCall et al., 2017), we observed a significant interaction of sex and cocaine dose in DATCre(+):Girk2fl/fl mice (F(3,54) = 4.133, p = 0.010); as such, males and females were analyzed separately. We did not observe a difference in total distance traveled by males on the first day (handling [H]) of exposure to the open field (Fig. 2E); however, female Cre+ mice traveled further than Cre− mice (Fig. 2E), an observation that aligns with our previous report (McCall et al., 2017). This genotype difference in female mice is not observed on saline day 2 (S2; Fig. 2F, 0 mg/kg cocaine), suggesting that the significant effect on handling day may be driven by a difference in exploration, rather than purely motor activity. Similar to our previous findings with acute cocaine administration (McCall et al., 2017), male and female DATCre(+):Girk2fl/fl mice exhibit increased locomotor activity at 15 mg/kg cocaine, and female Cre+ mice do not respond to 30 mg/kg cocaine as much as male Cre+ mice (Fig. 2F). Overall, our findings support the hypothesis that reduced GIRK channel activity in DA neurons increases behavioral sensitivity to cocaine.

Reduced GIRK channel activity in VTA DA neurons increases cocaine sensitivity

Having recapitulated findings related to depression-like behavior (Honda et al., 2018) and cocaine sensitivity (McCall et al., 2017) for DATCre:Girk2fl/fl mice using this behavioral test battery, we next assessed the behavioral impact of viral suppression of GIRK channel activity in adult VTA DA neurons. To do this, we compared the behavioral performance of DATCre(+) mice treated with control or GIRK3 overexpression vectors (Fig. 3A). No difference was detected between control and GIRK3 overexpression groups in percent time spent in open arms in the EPM (Fig. 3B). Additionally, there was no difference in percent time spent in closed arms (control, 53 ± 5%; GIRK3, 57 ± 3%; Mann–Whitney test, U = 109, p = 0.706), number of entries into open arms (control, 10 ± 1 entries; GIRK3, 9 ± 1 entries; t test, t(29) = 0.711, p = 0.483), or number of entries into closed arms (control, 10 ± 1 entries; GIRK3, 11 ± 1 entries; t test, t(29) = 0.367, p = 0.716). Similarly, no group differences were observed in total immobility time (Fig. 3C), or latency to immobility (control, 70 ± 8 s; GIRK3, 76 ± 10 s; t test, t(21) = 0.476, p = 0.639) in the FST. No difference was observed in locomotor activity on the handling day or saline day 2 between control and GIRK3 overexpression conditions (Fig. 3D,E). We did, however, observe a significant interaction between cocaine dose and viral treatment, with DATCre(+) mice treated with the GIRK3 virus exhibiting significantly enhanced locomotor activity at the 15 mg/kg cocaine dose (Fig. 3E). Thus, viral suppression of GIRK channel activity in adult VTA DA neurons elicits a selective and dose-dependent enhancement of cocaine-induced motor activity, without impacting anxiety- or depression-like behaviors.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Viral suppression of GIRK channel activity in VTA DA neurons increases behavioral sensitivity to cocaine. A, DATCre(+) mice were injected with control or GIRK3 virus. Mice were tested for EPM, FST, and cocaine locomotor activity 3 weeks after surgery, with each task separated by at least 1 d. Following behavior, mice were processed for placement and electrophysiology validation. B, EPM percent time in open arms is not different in control mice (n = 17, 33 ± 5%) and GIRK3 mice (n = 14, 30 ± 3%; t test, t(29) = 0.396, p = 0.695). C, FST time immobile during the final 4 min of the task does not differ between control mice (n = 12, 112 ± 13 s) and GIRK3 mice (n = 11, 131 ± 14 s; t test, t(21) = 0.957, p = 0.350). D, Distance moved on the handling habituation day was not different between control mice (n = 17, 119 ± 6 m/h) and GIRK3 (n = 15, 126 ± 9 m/h; t test, t(30) = 0.630, p = 0.534). E, Distanced traveled following injection of 0, 3, 15, and 30 mg/kg cocaine resulted in interaction between cocaine dose and virus (two-way repeated-measures ANOVA, F(3,90) = 3.438, p = 0.020; Bonferroni post hoc test at 15 mg/kg cocaine, t = 4.111, p < 0.001). F, Representative images of viral spread in horizontal slices from a mouse in the control condition, imaged at 2× just before electrophysiology, and summary of viral spread for all mice in control and GIRK3 conditions. MT, Medial terminal nucleus of the accessory optic tract; SNC, substantia nigra, compact part; SNCD, substantia nigra, compact part, dorsal tier; SNR, substantia nigra, reticular part; PBP, parabrachial pigmented nucleus of the VTA; PIF, parainterfascicular nucleus of the VTA; PN, paranigral nucleus of the VTA; VTAR, ventral tegmental area, rostral part. G, GABABR-GIRK currents in the GIRK3 group (n = 9 cells from 8 mice, 38 ± 7 pA) are significantly smaller than those in the control virus condition (n = 10 cells from 6 mice, 255 ± 21 pA; Mann–Whitney U test, U = 0.0, p < 0.0001). H, D2R-GIRK currents in the GIRK3 group (n = 9 cells from 7 mice, 22 ± 4 pA) are significantly smaller than those in the control virus condition (n = 8 cells from 6 mice, 52 ± 12 pA; Mann–Whitney U test, U = 11.50, p = 0.021). *p < 0.05. ***p < 0.001.

Following behavioral testing, mice were prepared for slice electrophysiological evaluation, and the extent of viral spread was summarized for control and GIRK3 overexpression conditions (Fig. 3F). As we found in behaviorally naive subjects (Fig. 1G), GABABR-dependent somatodendritic currents were significantly smaller in fluorescent VTA neurons in the GIRK3 overexpression group compared with controls (Fig. 3G). Similarly, somatodendritic currents evoked by a maximal concentration of the D2R agonist quinpirole (20 μm) were significantly decreased in the GIRK3 overexpression group (Fig. 3H). Thus, results from our initial viral validation and post hoc analysis suggest that GIRK3 overexpression suppresses GIRK channel activity evoked by GABABR and D2R in VTA DA neurons throughout the entire duration of behavioral testing.

Increased GIRK channel activity in VTA DA neurons decreases cocaine sensitivity

We next assessed the behavioral effect of enhancing GIRK channel activity in VTA DA neurons (Fig. 4A). There was no difference between control and GIRK2 overexpression groups in percent time spent in open arms of the EPM (Fig. 4B). Additionally, there was no difference in percent time spent in closed arms (control, 53 ± 4%; GIRK2, 57 ± 5%; t test, t(31) = 0.692, p = 0.494), number of entries into open arms (control, 11 ± 1 entries; GIRK2, 9 ± 1 entries; t test, t(31) = 1.107, p = 0.277), or number of entries into closed arms (control, 10 ± 1 entries; GIRK2, 10 ± 1 entries; t test, t(31) = 0.254, p = 0.801). We did not observe a significant difference in time immobile during the FST (Fig. 4C), nor did we observe any difference in latency to immobility between control (61 ± 6 s) and GIRK2 (69 ± 11 s; Mann–Whitney test, U = 83, p = 0.519) viral conditions. We also found no difference in locomotor activity on the handling day or saline day 2 (Fig. 4D,E). There was a significant interaction of viral condition and cocaine dose, with mice in the GIRK2 overexpression group responding significantly less at the 15 and 30 mg/kg cocaine doses (Fig. 4E). Thus, increasing the strength of GIRK channel activity in VTA DA neurons decreases behavioral sensitivity to cocaine, without impacting anxiety- or depression-like behaviors.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Viral enhancement of GIRK channel activity in VTA DA neurons decreases behavioral sensitivity to cocaine. A, Schematic of experiment, in which DATCre(+) mice were injected with control of GIRK2 virus. Three weeks following surgery, mice were tested for EPM, FST, and cocaine locomotor activity, with each task separated by at least 1 d. Following behavior, mice were processed for placement and electrophysiology validation. B, EPM percent time in open arms is not different in control mice (n = 17, 31 ± 4%) and GIRK2 mice (n = 16, 32 ± 5%; t test, t(31) = 0.1446, p = 0.8860). C, FST time immobile during the final 4 min of the task does not differ between control mice (n = 13, 137 ± 8 s) and GIRK2 mice (n = 15, 119 ± 12 s; Mann–Whitney U test, U = 76, p = 0.3334). D, Distance moved on the handling habituation day was not different between control mice (n = 16, 114 ± 8 m/h) and GIRK2 mice (n = 16, 123 ± 9 m/h; Mann–Whitney U test, U = 119, p = 0.7487). E, Distanced traveled following injection of 0, 3, 15, and 30 mg/kg cocaine resulted in interaction between cocaine dose and virus (two-way repeated-measures ANOVA, F(3,90) = 3.054, p = 0.032; Bonferroni post hoc test for 15 mg/kg, t = 2.548, p = 0.012, for 30 mg/kg, t = 2.824, p = 0.006). F, Representative images of viral spread in horizontal slices from a mouse in the control condition, imaged at 2× just before electrophysiology, and summary of viral spread for all mice in control and GIRK2 conditions. MT, Medial terminal nucleus of the accessory optic tract; SNC, substantia nigra, compact part; SNCD, substantia nigra, compact part, dorsal tier; SNR, substantia nigra, reticular part; PBP, parabrachial pigmented nucleus of the VTA; PIF, parainterfascicular nucleus of the VTA; PN, paranigral nucleus of the VTA; VTAR, ventral tegmental area, rostral part. G, GABABR-GIRK currents in the GIRK2 condition (n = 9 cells from 7 mice, 566 ± 77 pA) are significantly higher than those in the control condition (n = 10 cells from 7 mice, 265 ± 28 pA; Mann–Whitney U test, U = 14, p = 0.010). H, D2R-GIRK currents are not significantly different in control (n = 8 cells from 5 mice, 62 ± 9 pA) and GIRK2 conditions (n = 8 cells from 7 mice, 113 ± 25 pA; Mann–Whitney U test, U = 19.50, p = 0.207). *p < 0.05.

Following behavioral testing, control and GIRK2 overexpression mice were prepared for slice electrophysiological evaluation, and the extent of viral spread was summarized for control and GIRK2 overexpression conditions (Fig. 4F). Similar to our electrophysiological findings before behavioral testing (Fig. 1F), GABABR-dependent currents were significantly enhanced following GIRK2 overexpression, compared with control virus (Fig. 4G). However, D2R-GIRK currents in the GIRK2 overexpression condition were not significantly different from controls (Fig. 4H). The D2R-dependent response was heterogeneous, however, and the range of data in the GIRK2 overexpression group was substantially larger than that of the control condition (F test to compare variances, F(7,7) = 6.774, p = 0.022; Fig. 4H). This suggests that the overexpression of GIRK2 could alter the strength of D2R-GIRK channel-mediated signaling in some, but not all, DA neurons.

Discussion

Here, we used a viral approach to bidirectionally manipulate the strength of GIRK channel activity in VTA DA neurons of adult mice. We found that behavioral sensitivity to cocaine was inversely proportional to the strength of GIRK channel activity in VTA DA neurons, whereas negative affective behaviors were unaltered by VTA DA neuron-specific GIRK channel manipulations. These findings show that GIRK channel activity in VTA DA neurons can influence behavioral sensitivity to cocaine and suggest that manipulation of these channels could represent a new therapeutic approach to treating certain aspects of addiction. This prospect is enhanced by the fact that the GIRK2/GIRK3 channel subtype expressed in DA neurons is unique (Cruz et al., 2004; Labouèbe et al., 2007; Arora et al., 2010). Given that VTA DA neurons appear to be most influential in the early phase of addiction (i.e., binge/intoxication) (Volkow et al., 2012), an agonist selective for GIRK2/GIRK3 channels might be expected to suppress drug reward and acquisition of self-administration, without altering negative affective behavior.

GIRK channel activity in VTA DA neurons shapes behavioral sensitivity to cocaine

Our previous work demonstrated genetic ablation of GIRK channels globally or in DA neurons increased behavioral sensitivity to cocaine (Arora et al., 2010; McCall et al., 2017). Similarly, the DA neuron-specific ablation of sorting nexin 27 (SNX27), a cytoplasmic protein that interacts with the PDZ-binding motifs of GIRK2c and GIRK3 to regulate channel trafficking, decreased GABABR- and D2R-GIRK signaling and increased behavioral responding to cocaine (Lunn et al., 2007; Munoz and Slesinger, 2014; Rifkin et al., 2018). D2Rs in DA neurons have also been implicated in modulating behavioral sensitivity to cocaine. Indeed, mice lacking D2R in DA neurons display increased cocaine-induced locomotor activity, increased preference for a low dose of cocaine in the conditioned place preference test, and accelerated acquisition of self-administration (Bello et al., 2011; Holroyd et al., 2015). The interpretation of these DA neuron-specific genetic manipulations is limited by their congenital nature and lack of regional selectivity, which makes it challenging to dissociate them from developmental alterations and to attribute behavioral phenotypes to a specific dopaminergic population. Here, we report that genetic enhancement or suppression of GIRK-dependent signaling in adult mouse VTA DA neurons decreased or increased, respectively, behavioral sensitivity to cocaine.

The impact of VTA DA neuron GIRK channels on behavioral sensitivity to cocaine is likely attributable in large part to the engagement of GABABR- and/or D2R-dependent signaling by cocaine. Indeed, increased synaptic DA levels evoked by cocaine activates both terminal and somatodendritic D2Rs (Brodie and Dunwiddie, 1990; Beckstead et al., 2004). In addition, cocaine enhances GABAergic (“long-loop”) feedback to VTA DA neurons by increasing DA in the NAc (Edwards et al., 2017). While VTA DA neurons receive GABAergic input from local interneurons and several regions (Morales and Margolis, 2017), NAc-derived input from D1R-expressing medium spiny neurons appears to selectively activate GABABRs in VTA DA neurons (Edwards et al., 2017; Yang et al., 2018). Notably, recent studies targeting D2R in VTA DA neurons have yielded outcomes of comparable magnitude as those reported herein following viral suppression of GIRK channel activity. For example, RNAi-dependent suppression of D2R in the rat VTA correlates with increased cocaine locomotor activity, as well as increased responding for cocaine and sucrose in a self-administration progressive ratio task (de Jong et al., 2015). Similarly, GABABR ablation in VTA DA neurons correlated with increased cocaine-induced locomotor activity in mice (Edwards et al., 2017). It is important to note, however, that GIRK channels may mediate the effects of other inhibitory G protein-coupled receptors on VTA DA neurons, such as κ opioid and nociceptin receptors (Di Giannuario and Pieretti, 2000; Lutfy et al., 2001; Margolis et al., 2003; Ford et al., 2006). As such, the behavioral impact of VTA DA neuron-specific manipulations on GIRK channel activity may reflect in part the modulation of signaling via these receptors as well.

Suppression of VTA DA neuron GIRK channel activity by GIRK3

Similar to other published results (Kofuji et al., 1995; Lesage et al., 1995; Ma et al., 2002), we found that overexpression of GIRK3 neurons yielded a robust suppression of GIRK channel activity in VTA DA neurons. The molecular mechanisms underlying this dominant negative influence of ectopic GIRK3 are unclear. Overexpression of GIRK3 may enhance trafficking of GIRK channels to internal sites, a prospect supported by the presence of a lysosomal targeting motif in the GIRK3 carboxyl-terminal domain (Ma et al., 2002). GIRK3 might promote an interaction between the VTA DA neuron GIRK channel and SNX27, which can bidirectionally regulate channel trafficking (Lunn et al., 2007; Munoz and Slesinger, 2014). The presence of GIRK3 could also increase the negative regulatory influence of regulator of G protein signaling 2 (RGS2) on GIRK-dependent signaling in VTA DA neurons (Jelacic et al., 2000; Labouèbe et al., 2007). Interestingly, activity-dependent and pyschostimulant-induced plasticity of GIRK channel activity in VTA DA neurons is dependent upon GIRK3 (Lalive et al., 2014; Munoz et al., 2016). Given these observations, it is tempting to speculate that GIRK3 titrates the strength of GIRK channel activity in VTA DA neurons via the extent to which it incorporates into the GIRK2/GIRK3 heterotetromeric channel.

GIRK channels and negative affective behavior

Girk2−/− mice display reduced anxiety- and depression-related behaviors, which are modulated by DA (Pravetoni and Wickman, 2008; Llamosas et al., 2015; Zarrindast and Khakpai, 2015; Belujon and Grace, 2017). While viral manipulation of GIRK channel activity in VTA DA neurons did not alter these behaviors, male DATCre(+):Girk2fl/fl mice displayed decreased depression-related behavior, congruent with findings from another DATCre:Girk2fl/fl line (Honda et al., 2018). The apparent discrepancy in depression-related behavior in DATCre(+):Girk2fl/fl mice and the viral loss-of-function model could reflect a lack of penetrance in the viral manipulation, developmental compensation in DATCre(+):Girk2fl/fl mice, or the influence of a different, non-VTA population of DA neurons on this behavior.

The lack of anxiolytic phenotype in DATCre(+):Girk2fl/fl and viral gain- and loss-of-function models suggests that GIRK-dependent signaling in VTA DA neurons does not contribute to baseline anxiety-related behavior. The anxiolytic phenotype observed in both Girk1−/− and Girk2−/− mice, and the anxiolytic efficacy of a direct-acting agonist of GIRK1-containing channels (ML297), support the contention that neuron populations expressing GIRK1-containing channels impact baseline anxiety in mice, not the GIRK1-lacking midbrain DA neurons (Cruz et al., 2004; Pravetoni and Wickman, 2008; Wydeven et al., 2014).

Overall, the outcomes of our viral manipulations suggest that GIRK-dependent signaling in VTA DA neurons exerts a minimal influence on negative affective behavior at baseline. However, the prior experience of subjects in our study is meaningfully distinct from that of mice in studies in which VTA DA neuron excitability was shown to correlate with altered negative affective behavior. Indeed, mice subjected to social defeat stress that subsequently displayed depressive-like behavior (“susceptible” mice) also displayed increased VTA DA neuron excitability (Cao et al., 2010; Chaudhury et al., 2013; Friedman et al., 2014, 2016). In this context, it is noteworthy that, while our viral manipulations did alter the amplitude of GIRK-dependent somatodendritic currents in VTA DA neurons, they exerted little or no impact on the excitability of VTA DA neurons (Table 1).

Future directions

A rich body of recent work has demonstrated that separate dopaminergic projections emanating from the VTA participate in distinct behaviors (Lammel et al., 2014; Holly and Miczek, 2016; Juarez and Han, 2016; Morales and Margolis, 2017). For example, DA neurons in the lateral VTA, which project to the lateral NAc shell, are responsive to rewarding stimuli (Lammel et al., 2011, 2012). In contrast, more medial VTA DA neurons projecting to the PFC and the core and medial shell of the NAc have been implicated in responding to aversive stimuli (Lammel et al., 2008, 2012; Vander Weele et al., 2018; de Jong et al., 2019). Interestingly, although overexpression of GIRK2 enhanced GABABR-GIRK signaling in VTA DA neurons, we did not observe a significant increase in D2R-GIRK signaling with this manipulation (Fig. 4H). Rather, there appeared to be two distinct populations of VTA DA neurons in our study: one with unaltered D2R-GIRK responses and one with enhanced responses. It is possible that D2Rs and GIRK channels are maximally coupled in the former population (e.g., D2R level is the factor limiting D2R-GIRK signaling strength), which renders overexpression of GIRK2 functionally inert. In the latter population, the GIRK channel level may limit the strength of D2R-GIRK signaling at baseline. It is possible that this diversity of D2R-GIRK signaling aligns with distinct, projection-defined subpopulations of VTA DA neurons (Lammel et al., 2008). Further investigation will be needed to determine whether GIRK-dependent signaling in discrete VTA DA neuron projections mediates behavioral sensitivity to cocaine, and whether selective strengthening of GIRK channel activity in these projections might suppress other cocaine-related behaviors, including acquisition of self-administration or reinstatement.

Footnotes

  • This work was supported by National Institutes of Health Grant DA034696 to K.W. and Grant DA041767 to N.M.M. We thank Nicholas Carlblom, Hannah Oberle, Zhilian Xia, and JingYing Zhang for care of the mouse colony; Dr. Megan Tipps for providing training in intracranial surgeries and discussing the manuscript; Dr. Yasushi Nakagawa for assistance with the immunohistochemistry studies; Nihan Gencerliler for helping with the design and initial testing of the GIRK3 expression vector; and Dr. Mark Sanders and Yung Kim (University of Minnesota University Imaging Centers) for microscopy support.

  • The authors declare no competing financial interests.

  • Correspondence should be addressed to Kevin Wickman at wickm002{at}umn.edu

References

  1. ↵
    1. Anstrom KK,
    2. Woodward DJ
    (2005) Restraint increases dopaminergic burst firing in awake rats. Neuropsychopharmacology 30:1832–1840. doi:10.1038/sj.npp.1300730 pmid:15886724
    OpenUrlCrossRefPubMed
  2. ↵
    1. Aragona BJ,
    2. Cleaveland NA,
    3. Stuber GD,
    4. Day JJ,
    5. Carelli RM,
    6. Wightman RM
    (2008) Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J Neurosci 28:8821–8831. doi:10.1523/JNEUROSCI.2225-08.2008 pmid:18753384
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Arora D,
    2. Haluk DM,
    3. Kourrich S,
    4. Pravetoni M,
    5. Fernández-Alacid L,
    6. Nicolau JC,
    7. Luján R,
    8. Wickman K
    (2010) Altered neurotransmission in the mesolimbic reward system of Girk mice. J Neurochem 114:1487–1497. doi:10.1111/j.1471-4159.2010.06864.x pmid:20557431
    OpenUrlCrossRefPubMed
  4. ↵
    1. Arora D,
    2. Hearing M,
    3. Haluk DM,
    4. Mirkovic K,
    5. Fajardo-Serrano A,
    6. Wessendorf MW,
    7. Watanabe M,
    8. Luján R,
    9. Wickman K
    (2011) Acute cocaine exposure weakens GABA(B) receptor-dependent G-protein-gated inwardly rectifying K+ signaling in dopamine neurons of the ventral tegmental area. J Neurosci 31:12251–12257. doi:10.1523/JNEUROSCI.0494-11.2011 pmid:21865468
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Bäckman CM,
    2. Malik N,
    3. Zhang Y,
    4. Shan L,
    5. Grinberg A,
    6. Hoffer BJ,
    7. Westphal H,
    8. Tomac AC
    (2006) Characterization of a mouse strain expressing Cre recombinase from the 3′ untranslated region of the dopamine transporter locus. Genesis 44:383–390. doi:10.1002/dvg.20228 pmid:16865686
    OpenUrlCrossRefPubMed
  6. ↵
    1. Beckstead MJ,
    2. Grandy DK,
    3. Wickman K,
    4. Williams JT
    (2004) Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 42:939–946. doi:10.1016/j.neuron.2004.05.019 pmid:15207238
    OpenUrlCrossRefPubMed
  7. ↵
    1. Bello EP,
    2. Mateo Y,
    3. Gelman DM,
    4. Noaín D,
    5. Shin JH,
    6. Low MJ,
    7. Alvarez VA,
    8. Lovinger DM,
    9. Rubinstein M
    (2011) Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat Neurosci 14:1033–1038. doi:10.1038/nn.2862 pmid:21743470
    OpenUrlCrossRefPubMed
  8. ↵
    1. Belujon P,
    2. Grace AA
    (2017) Dopamine system dysregulation in major depressive disorders. Int J Neuropsychopharmacol 20:1036–1046. doi:10.1093/ijnp/pyx056 pmid:29106542
    OpenUrlCrossRefPubMed
  9. ↵
    1. Blednov YA,
    2. Stoffel M,
    3. Chang SR,
    4. Harris RA
    (2001) Potassium channels as targets for ethanol: studies of G-protein-coupled inwardly rectifying potassium channel 2 (GIRK2) null mutant mice. J Pharmacol Exp Ther 298:521–530. pmid:11454913
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Blednov YA,
    2. Stoffel M,
    3. Alva H,
    4. Harris RA
    (2003) A pervasive mechanism for analgesia: activation of GIRK2 channels. Proc Natl Acad Sci U S A 100:277–282. doi:10.1073/pnas.012682399 pmid:12493843
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Brodie MS,
    2. Dunwiddie TV
    (1990) Cocaine effects in the ventral tegmental area: evidence for an indirect dopaminergic mechanism of action. Naunyn Schmiedebergs Arch Pharmacol 342:660–665. doi:10.1007/BF00175709 pmid:2096297
    OpenUrlCrossRefPubMed
  12. ↵
    1. Cao JL,
    2. Covington HE 3rd.,
    3. Friedman AK,
    4. Wilkinson MB,
    5. Walsh JJ,
    6. Cooper DC,
    7. Nestler EJ,
    8. Han MH
    (2010) Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action. J Neurosci 30:16453–16458. doi:10.1523/JNEUROSCI.3177-10.2010 pmid:21147984
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Chaudhury D,
    2. Walsh JJ,
    3. Friedman AK,
    4. Juarez B,
    5. Ku SM,
    6. Koo JW,
    7. Ferguson D,
    8. Tsai HC,
    9. Pomeranz L,
    10. Christoffel DJ,
    11. Nectow AR,
    12. Ekstrand M,
    13. Domingos A,
    14. Mazei-Robison MS,
    15. Mouzon E,
    16. Lobo MK,
    17. Neve RL,
    18. Friedman JM,
    19. Russo SJ,
    20. Deisseroth K, et al
    . (2013) Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493:532–536. doi:10.1038/nature11713 pmid:23235832
    OpenUrlCrossRefPubMed
  14. ↵
    1. Costa AC,
    2. Stasko MR,
    3. Stoffel M,
    4. Scott-McKean JJ
    (2005) G-protein-gated potassium (GIRK) channels containing the GIRK2 subunit are control hubs for pharmacologically induced hypothermic responses. J Neurosci 25:7801–7804. doi:10.1523/JNEUROSCI.1699-05.2005 pmid:16120781
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Cruz HG,
    2. Ivanova T,
    3. Lunn ML,
    4. Stoffel M,
    5. Slesinger PA,
    6. Lüscher C
    (2004) Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system. Nat Neurosci 7:153–159. doi:10.1038/nn1181 pmid:14745451
    OpenUrlCrossRefPubMed
  16. ↵
    1. de Jong JW,
    2. Roelofs TJ,
    3. Mol FM,
    4. Hillen AE,
    5. Meijboom KE,
    6. Luijendijk MC,
    7. van der Eerden HA,
    8. Garner KM,
    9. Vanderschuren LJ,
    10. Adan RA
    (2015) Reducing ventral tegmental dopamine D2 receptor expression selectively boosts incentive motivation. Neuropsychopharmacology 40:2085–2095. doi:10.1038/npp.2015.60 pmid:25735756
    OpenUrlCrossRefPubMed
  17. ↵
    1. de Jong JW,
    2. Afjei SA,
    3. Pollak Dorocic I,
    4. Peck JR,
    5. Liu C,
    6. Kim CK,
    7. Tian L,
    8. Deisseroth K,
    9. Lammel S
    (2019) A neural circuit mechanism for encoding aversive stimuli in the mesolimbic dopamine system. Neuron 101:133–151.e7. doi:10.1016/j.neuron.2018.11.005 pmid:30503173
    OpenUrlCrossRefPubMed
  18. ↵
    1. Demaria JE,
    2. Nagy GM,
    3. Lerant AA,
    4. Fekete MI,
    5. Levenson CW,
    6. Freeman ME
    (2000) Dopamine transporters participate in the physiological regulation of prolactin. Endocrinology 141:366–374. doi:10.1210/endo.141.1.7281 pmid:10614659
    OpenUrlCrossRefPubMed
  19. ↵
    1. Di Chiara G,
    2. Imperato A
    (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274–5278. doi:10.1073/pnas.85.14.5274 pmid:2899326
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Di Giannuario A,
    2. Pieretti S
    (2000) Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats. Peptides 21:1125–1130. doi:10.1016/S0196-9781(00)00250-3 pmid:10998547
    OpenUrlCrossRefPubMed
  21. ↵
    1. Edwards NJ,
    2. Tejeda HA,
    3. Pignatelli M,
    4. Zhang S,
    5. McDevitt RA,
    6. Wu J,
    7. Bass CE,
    8. Bettler B,
    9. Morales M,
    10. Bonci A
    (2017) Circuit specificity in the inhibitory architecture of the VTA regulates cocaine-induced behavior. Nat Neurosci 20:438–448. doi:10.1038/nn.4482 pmid:28114294
    OpenUrlCrossRefPubMed
  22. ↵
    1. Ford CP
    (2014) The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience 282:13–22. doi:10.1016/j.neuroscience.2014.01.025 pmid:24463000
    OpenUrlCrossRefPubMed
  23. ↵
    1. Ford CP,
    2. Mark GP,
    3. Williams JT
    (2006) Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 26:2788–2797. doi:10.1523/JNEUROSCI.4331-05.2006 pmid:16525058
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Franklin KB,
    2. Paxinos G
    (2008) The mouse brain in stereotaxic coordinates, Ed 3. San Diego: Academic.
  25. ↵
    1. Friedman AK,
    2. Walsh JJ,
    3. Juarez B,
    4. Ku SM,
    5. Chaudhury D,
    6. Wang J,
    7. Li X,
    8. Dietz DM,
    9. Pan N,
    10. Vialou VF,
    11. Neve RL,
    12. Yue Z,
    13. Han MH
    (2014) Enhancing depression mechanisms in midbrain dopamine neurons achieves homeostatic resilience. Science 344:313–319. doi:10.1126/science.1249240 pmid:24744379
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Friedman AK,
    2. Juarez B,
    3. Ku SM,
    4. Zhang H,
    5. Calizo RC,
    6. Walsh JJ,
    7. Chaudhury D,
    8. Zhang S,
    9. Hawkins A,
    10. Dietz DM,
    11. Murrough JW,
    12. Ribadeneira M,
    13. Wong EH,
    14. Neve RL,
    15. Han MH
    (2016) KCNQ channel openers reverse depressive symptoms via an active resilience mechanism. Nat Commun 7:11671. doi:10.1038/ncomms11671 pmid:27216573
    OpenUrlCrossRefPubMed
  27. ↵
    1. Hall F,
    2. Sora I,
    3. Drgonova J,
    4. Li X,
    5. Goeb M,
    6. Uhl G
    (2004) Molecular mechanisms underlying the rewarding effects of cocaine. Ann N Y Acad Sci 1025:47–56. doi:10.1196/annals.1316.006 pmid:15542699
    OpenUrlCrossRefPubMed
  28. ↵
    1. Hearing MC,
    2. Zink AN,
    3. Wickman K
    (2012) Cocaine-induced adaptations in metabotropic inhibitory signaling in the mesocorticolimbic system. Rev Neurosci 23:325–351. doi:10.1515/revneuro-2012-0045 pmid:22944653
    OpenUrlCrossRefPubMed
  29. ↵
    1. Hearing M,
    2. Kotecki L,
    3. Marron Fernandez de Velasco E,
    4. Fajardo-Serrano A,
    5. Chung HJ,
    6. Luján R,
    7. Wickman K
    (2013) Repeated cocaine weakens GABAB-GIRK signaling in layer 5/6 pyramidal neurons in the prelimbic cortex. Neuron 80:159–170. doi:10.1016/j.neuron.2013.07.019 pmid:24094109
    OpenUrlCrossRefPubMed
  30. ↵
    1. Holly EN,
    2. Miczek KA
    (2016) Ventral tegmental area dopamine revisited: effects of acute and repeated stress. Psychopharmacology (Berl) 233:163–186. doi:10.1007/s00213-015-4151-3 pmid:26676983
    OpenUrlCrossRefPubMed
  31. ↵
    1. Holroyd KB,
    2. Adrover MF,
    3. Fuino RL,
    4. Bock R,
    5. Kaplan AR,
    6. Gremel CM,
    7. Rubinstein M,
    8. Alvarez VA
    (2015) Loss of feedback inhibition via D2 autoreceptors enhances acquisition of cocaine taking and reactivity to drug-paired cues. Neuropsychopharmacology 40:1495–1509. doi:10.1038/npp.2014.336 pmid:25547712
    OpenUrlCrossRefPubMed
  32. ↵
    1. Honda I,
    2. Araki K,
    3. Honda S,
    4. Soeda F,
    5. Shin MC,
    6. Misumi S,
    7. Yamamura KI,
    8. Takahama K
    (2018) Deletion of GIRK2 subunit containing GIRK channels of neurons expressing dopamine transporter decrease immobility time on forced swimming in mice. Neurosci Lett 665:140–146. doi:10.1016/j.neulet.2017.11.028 pmid:29180115
    OpenUrlCrossRefPubMed
  33. ↵
    1. Jelacic TM,
    2. Kennedy ME,
    3. Wickman K,
    4. Clapham DE
    (2000) Functional and biochemical evidence for G-protein-gated inwardly rectifying K+ (GIRK) channels composed of GIRK2 and GIRK3. J Biol Chem 275:36211–36216. doi:10.1074/jbc.M007087200 pmid:10956667
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Juarez B,
    2. Han MH
    (2016) Diversity of dopaminergic neural circuits in response to drug exposure. Neuropsychopharmacology 41:2424–2446. doi:10.1038/npp.2016.32 pmid:26934955
    OpenUrlCrossRefPubMed
  35. ↵
    1. Kofuji P,
    2. Davidson N,
    3. Lester HA
    (1995) Evidence that neuronal G-protein-gated inwardly rectifying K+ channels are activated by G beta gamma subunits and function as heteromultimers. Proc Natl Acad Sci U S A 92:6542–6546. doi:10.1073/pnas.92.14.6542 pmid:7604029
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Kotecki L,
    2. Hearing M,
    3. McCall NM,
    4. Marron Fernandez de Velasco E,
    5. Pravetoni M,
    6. Arora D,
    7. Victoria NC,
    8. Munoz MB,
    9. Xia Z,
    10. Slesinger PA,
    11. Weaver CD,
    12. Wickman K
    (2015) GIRK channels modulate opioid-induced motor activity in a cell type- and subunit-dependent manner. J Neurosci 35:7131–7142. doi:10.1523/JNEUROSCI.5051-14.2015 pmid:25948263
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Krishnan V,
    2. Han MH,
    3. Graham DL,
    4. Berton O,
    5. Renthal W,
    6. Russo SJ,
    7. Laplant Q,
    8. Graham A,
    9. Lutter M,
    10. Lagace DC,
    11. Ghose S,
    12. Reister R,
    13. Tannous P,
    14. Green TA,
    15. Neve RL,
    16. Chakravarty S,
    17. Kumar A,
    18. Eisch AJ,
    19. Self DW,
    20. Lee FS, et al
    . (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131:391–404. doi:10.1016/j.cell.2007.09.018 pmid:17956738
    OpenUrlCrossRefPubMed
  38. ↵
    1. Labouèbe G,
    2. Lomazzi M,
    3. Cruz HG,
    4. Creton C,
    5. Luján R,
    6. Li M,
    7. Yanagawa Y,
    8. Obata K,
    9. Watanabe M,
    10. Wickman K,
    11. Boyer SB,
    12. Slesinger PA,
    13. Lüscher C
    (2007) RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area. Nat Neurosci 10:1559–1568. doi:10.1038/nn2006 pmid:17965710
    OpenUrlCrossRefPubMed
  39. ↵
    1. Lalive AL,
    2. Munoz MB,
    3. Bellone C,
    4. Slesinger PA,
    5. Lüscher C,
    6. Tan KR
    (2014) Firing modes of dopamine neurons drive bidirectional GIRK channel plasticity. J Neurosci 34:5107–5114. doi:10.1523/JNEUROSCI.5203-13.2014 pmid:24719090
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Lammel S,
    2. Hetzel A,
    3. Häckel O,
    4. Jones I,
    5. Liss B,
    6. Roeper J
    (2008) Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57:760–773. doi:10.1016/j.neuron.2008.01.022 pmid:18341995
    OpenUrlCrossRefPubMed
  41. ↵
    1. Lammel S,
    2. Ion DI,
    3. Roeper J,
    4. Malenka RC
    (2011) Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 70:855–862. doi:10.1016/j.neuron.2011.03.025 pmid:21658580
    OpenUrlCrossRefPubMed
  42. ↵
    1. Lammel S,
    2. Lim BK,
    3. Ran C,
    4. Huang KW,
    5. Betley MJ,
    6. Tye KM,
    7. Deisseroth K,
    8. Malenka RC
    (2012) Input-specific control of reward and aversion in the ventral tegmental area. Nature 491:212–217. doi:10.1038/nature11527 pmid:23064228
    OpenUrlCrossRefPubMed
  43. ↵
    1. Lammel S,
    2. Lim BK,
    3. Malenka RC
    (2014) Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 76:351–359. doi:10.1016/j.neuropharm.2013.03.019 pmid:23578393
    OpenUrlCrossRefPubMed
  44. ↵
    1. Lammel S,
    2. Steinberg EE,
    3. Földy C,
    4. Wall NR,
    5. Beier K,
    6. Luo L,
    7. Malenka RC
    (2015) Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons. Neuron 85:429–438. doi:10.1016/j.neuron.2014.12.036 pmid:25611513
    OpenUrlCrossRefPubMed
  45. ↵
    1. Lesage F,
    2. Guillemare E,
    3. Fink M,
    4. Duprat F,
    5. Heurteaux C,
    6. Fosset M,
    7. Romey G,
    8. Barhanin J,
    9. Lazdunski M
    (1995) Molecular properties of neuronal G-protein-activated inwardly rectifying K+ channels. J Biol Chem 270:28660–28667. doi:10.1074/jbc.270.48.28660 pmid:7499385
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Llamosas N,
    2. Bruzos-Cidón C,
    3. Rodríguez JJ,
    4. Ugedo L,
    5. Torrecilla M
    (2015) Deletion of GIRK2 subunit of GIRK channels alters the 5-HT 1A receptor-mediated signaling and results in a depression-resistant behavior. Int J Neuropsychopharmacol 18:pyv051. doi:10.1093/ijnp/pyv051 pmid:25956878
    OpenUrlCrossRefPubMed
  47. ↵
    1. Lorang D,
    2. Amara SG,
    3. Simerly RB
    (1994) Cell-type-specific expression of catecholamine transporters in the rat brain. J Neurosci 14:4903–4914. doi:10.1523/JNEUROSCI.14-08-04903.1994 pmid:8046459
    OpenUrlAbstract/FREE Full Text
  48. ↵
    1. Luján R,
    2. Marron Fernandez de Velasco E,
    3. Aguado C,
    4. Wickman K
    (2014) New insights into the therapeutic potential of Girk channels. Trends Neurosci 37:20–29. doi:10.1016/j.tins.2013.10.006 pmid:24268819
    OpenUrlCrossRefPubMed
  49. ↵
    1. Lunn ML,
    2. Nassirpour R,
    3. Arrabit C,
    4. Tan J,
    5. McLeod I,
    6. Arias CM,
    7. Sawchenko PE,
    8. Yates JR 3rd.,
    9. Slesinger PA
    (2007) A unique sorting nexin regulates trafficking of potassium channels via a PDZ domain interaction. Nat Neurosci 10:1249–1259. doi:10.1038/nn1953 pmid:17828261
    OpenUrlCrossRefPubMed
  50. ↵
    1. Lutfy K,
    2. Do T,
    3. Maidment NT
    (2001) Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats. Psychopharmacology (Berl) 154:1–7. doi:10.1007/s002130000609 pmid:11291998
    OpenUrlCrossRefPubMed
  51. ↵
    1. Ma D,
    2. Zerangue N,
    3. Raab-Graham K,
    4. Fried SR,
    5. Jan YN,
    6. Jan LY
    (2002) Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart. Neuron 33:715–729. doi:10.1016/S0896-6273(02)00614-1 pmid:11879649
    OpenUrlCrossRefPubMed
  52. ↵
    1. Margolis EB,
    2. Hjelmstad GO,
    3. Bonci A,
    4. Fields HL
    (2003) Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci 23:9981–9986. doi:10.1523/JNEUROSCI.23-31-09981.2003 pmid:14602811
    OpenUrlAbstract/FREE Full Text
  53. ↵
    1. Marker CL,
    2. Stoffel M,
    3. Wickman K
    (2004) Spinal G-protein-pated K+ channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia. J Neurosci 24:2806–2812. doi:10.1523/JNEUROSCI.5251-03.2004 pmid:15028774
    OpenUrlAbstract/FREE Full Text
  54. ↵
    1. Marker CL,
    2. Luján R,
    3. Loh HH,
    4. Wickman K
    (2005) Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. J Neurosci 25:3551–3559. doi:10.1523/JNEUROSCI.4899-04.2005 pmid:15814785
    OpenUrlAbstract/FREE Full Text
  55. ↵
    1. Marron Fernandez de Velasco E,
    2. McCall N,
    3. Wickman K
    (2015) GIRK channel plasticity and implications for drug addiction. Int Rev Neurobiol 123:201–238. doi:10.1016/bs.irn.2015.05.011 pmid:26422986
    OpenUrlCrossRefPubMed
  56. ↵
    1. McCall NM,
    2. Kotecki L,
    3. Dominguez-Lopez S,
    4. Marron Fernandez de Velasco E,
    5. Carlblom N,
    6. Sharpe AL,
    7. Beckstead MJ,
    8. Wickman K
    (2017) Selective ablation of GIRK channels in dopamine neurons alters behavioral effects of cocaine in mice. Neuropsychopharmacology 42:707–715. doi:10.1038/npp.2016.138 pmid:27468917
    OpenUrlCrossRefPubMed
  57. ↵
    1. Meister B,
    2. Elde R
    (1993) Dopamine transporter mRNA in neurons of the rat hypothalamus. Neuroendocrinology 58:388–395. doi:10.1159/000126568 pmid:8284024
    OpenUrlCrossRefPubMed
  58. ↵
    1. Morales M,
    2. Margolis EB
    (2017) Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat Rev Neurosci 18:73–85. doi:10.1038/nrn.2016.165 pmid:28053327
    OpenUrlCrossRefPubMed
  59. ↵
    1. Morgan AD,
    2. Carroll ME,
    3. Loth AK,
    4. Stoffel M,
    5. Wickman K
    (2003) Decreased cocaine self-administration in Kir3 potassium channel subunit knockout mice. Neuropsychopharmacology 28:932–938. doi:10.1038/sj.npp.1300100 pmid:12637950
    OpenUrlCrossRefPubMed
  60. ↵
    1. Munoz MB,
    2. Slesinger PA
    (2014) Sorting nexin 27 regulation of G protein-gated inwardly rectifying K+ channels attenuates in vivo cocaine response. Neuron 82:659–669. doi:10.1016/j.neuron.2014.03.011 pmid:24811384
    OpenUrlCrossRefPubMed
  61. ↵
    1. Munoz MB,
    2. Padgett CL,
    3. Rifkin R,
    4. Terunuma M,
    5. Wickman K,
    6. Contet C,
    7. Moss SJ,
    8. Slesinger PA
    (2016) A role for the GIRK3 subunit in methamphetamine-induced attenuation of GABAB receptor-activated GIRK currents in VTA dopamine neurons. J Neurosci 36:3106–3114. doi:10.1523/JNEUROSCI.1327-15.2016 pmid:26985023
    OpenUrlAbstract/FREE Full Text
  62. ↵
    1. Nestler EJ,
    2. Carlezon WA Jr.
    (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151–1159. doi:10.1016/j.biopsych.2005.09.018 pmid:16566899
    OpenUrlCrossRefPubMed
  63. ↵
    1. Polter AM,
    2. Kauer JA
    (2014) Stress and VTA synapses: implications for addiction and depression. Eur J Neurosci 39:1179–1188. doi:10.1111/ejn.12490 pmid:24712997
    OpenUrlCrossRefPubMed
  64. ↵
    1. Pravetoni M,
    2. Wickman K
    (2008) Behavioral characterization of mice lacking GIRK/Kir3 channel subunits. Genes Brain Behav 7:523–531. doi:10.1111/j.1601-183X.2008.00388.x pmid:18194467
    OpenUrlCrossRefPubMed
  65. ↵
    1. Rifkin RA,
    2. Moss SJ,
    3. Slesinger PA
    (2017) G protein-gated potassium channels: a link to drug addiction. Trends Pharmacol Sci 38:378–392. doi:10.1016/j.tips.2017.01.007 pmid:28188005
    OpenUrlCrossRefPubMed
  66. ↵
    1. Rifkin RA,
    2. Huyghe D,
    3. Li X,
    4. Parakala M,
    5. Aisenberg E,
    6. Moss SJ,
    7. Slesinger PA
    (2018) GIRK currents in VTA dopamine neurons control the sensitivity of mice to cocaine-induced locomotor sensitization. Proc Natl Acad Sci U S A 115:E9479–E9488. doi:10.1073/pnas.1807788115 pmid:30228121
    OpenUrlAbstract/FREE Full Text
  67. ↵
    1. Rocha BA
    (2003) Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice. Eur J Pharmacol 479:107–115. doi:10.1016/j.ejphar.2003.08.061 pmid:14612142
    OpenUrlCrossRefPubMed
  68. ↵
    1. Russo SJ,
    2. Nestler EJ
    (2013) The brain reward circuitry in mood disorders. Nat Rev Neurosci 14:609–625. doi:10.1038/nrn3381 pmid:23942470
    OpenUrlCrossRefPubMed
  69. ↵
    1. Signorini S,
    2. Liao YJ,
    3. Duncan SA,
    4. Jan LY,
    5. Stoffel M
    (1997) Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2. Proc Natl Acad Sci U S A 94:923–927. doi:10.1073/pnas.94.3.923 pmid:9023358
    OpenUrlAbstract/FREE Full Text
  70. ↵
    1. Steketee JD,
    2. Kalivas PW
    (1991) Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region. J Pharmacol Exp Ther 259:916–924. pmid:1941636
    OpenUrlAbstract/FREE Full Text
  71. ↵
    1. Stuber GD,
    2. Stamatakis AM,
    3. Kantak PA
    (2015) Considerations when using Cre-driver rodent lines for studying ventral tegmental area circuitry. Neuron 85:439–445. doi:10.1016/j.neuron.2014.12.034 pmid:25611514
    OpenUrlCrossRefPubMed
  72. ↵
    1. Tye KM,
    2. Mirzabekov JJ,
    3. Warden MR,
    4. Ferenczi EA,
    5. Tsai HC,
    6. Finkelstein J,
    7. Kim SY,
    8. Adhikari A,
    9. Thompson KR,
    10. Andalman AS,
    11. Gunaydin LA,
    12. Witten IB,
    13. Deisseroth K
    (2013) Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 493:537–541. doi:10.1038/nature11740 pmid:23235822
    OpenUrlCrossRefPubMed
  73. ↵
    1. Vander Weele CM,
    2. Siciliano CA,
    3. Matthews GA,
    4. Namburi P,
    5. Izadmehr EM,
    6. Espinel IC,
    7. Nieh EH,
    8. Schut EH,
    9. Padilla-Coreano N,
    10. Burgos-Robles A,
    11. Chang CJ,
    12. Kimchi EY,
    13. Beyeler A,
    14. Wichmann R,
    15. Wildes CP,
    16. Tye KM
    (2018) Dopamine enhances signal-to-noise ratio in cortical-brainstem encoding of aversive stimuli. Nature 563:397–401. doi:10.1038/s41586-018-0682-1 pmid:30405240
    OpenUrlCrossRefPubMed
  74. ↵
    1. Volkow ND,
    2. Wang GJ,
    3. Fowler JS,
    4. Tomasi D
    (2012) Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol 52:321–336. doi:10.1146/annurev-pharmtox-010611-134625 pmid:21961707
    OpenUrlCrossRefPubMed
  75. ↵
    1. Wydeven N,
    2. Marron Fernandez de Velasco E,
    3. Du Y,
    4. Benneyworth MA,
    5. Hearing MC,
    6. Fischer RA,
    7. Thomas MJ,
    8. Weaver CD,
    9. Wickman K
    (2014) Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297. Proc Natl Acad Sci U S A 111:10755–10760. doi:10.1073/pnas.1405190111 pmid:25002517
    OpenUrlAbstract/FREE Full Text
  76. ↵
    1. Yang H,
    2. de Jong JW,
    3. Tak Y,
    4. Peck J,
    5. Bateup HS,
    6. Lammel S
    (2018) Nucleus accumbens subnuclei regulate motivated behavior via direct inhibition and disinhibition of VTA dopamine subpopulations. Neuron 97:434–449.e4. doi:10.1016/j.neuron.2017.12.022 pmid:29307710
    OpenUrlCrossRefPubMed
  77. ↵
    1. Zarrindast MR,
    2. Khakpai F
    (2015) The modulatory role of dopamine in anxiety-like behavior. Arch Iran Med 18:591–603. doi:0151809/AIM.009 pmid:26317601
    OpenUrlCrossRefPubMed
Back to top

In this issue

The Journal of Neuroscience: 39 (19)
Journal of Neuroscience
Vol. 39, Issue 19
8 May 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
GIRK Channel Activity in Dopamine Neurons of the Ventral Tegmental Area Bidirectionally Regulates Behavioral Sensitivity to Cocaine
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
GIRK Channel Activity in Dopamine Neurons of the Ventral Tegmental Area Bidirectionally Regulates Behavioral Sensitivity to Cocaine
Nora M. McCall, Ezequiel Marron Fernandez de Velasco, Kevin Wickman
Journal of Neuroscience 8 May 2019, 39 (19) 3600-3610; DOI: 10.1523/JNEUROSCI.3101-18.2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
GIRK Channel Activity in Dopamine Neurons of the Ventral Tegmental Area Bidirectionally Regulates Behavioral Sensitivity to Cocaine
Nora M. McCall, Ezequiel Marron Fernandez de Velasco, Kevin Wickman
Journal of Neuroscience 8 May 2019, 39 (19) 3600-3610; DOI: 10.1523/JNEUROSCI.3101-18.2019
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • D2 dopamine receptor
  • dopamine
  • G protein
  • GABAB
  • Kir3
  • VTA

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Articles

  • Cortically-evoked movement in humans reflects history of prior executions, not plan for upcoming movement
  • Neuronally-derived soluble Abeta evokes cell-wide astrocytic calcium dysregulation in absence of amyloid plaques in vivo
  • Effect of aging and a dual orexin receptor antagonist on sleep architecture and NREM oscillations including a REM Behavior Disorder phenotype in the PS19 mouse model of tauopathy
Show more Research Articles

Cellular/Molecular

  • Multiple Subthreshold GPCR Signals Combined by the G-Proteins Gαq and Gαs Activate the Caenorhabditis elegans Egg-Laying Muscles
  • The SphK1/S1P Axis Regulates Synaptic Vesicle Endocytosis via TRPC5 Channels
  • Ogt deficiency induces abnormal cerebellar function and behavioral deficits of adult mice through modulating RhoA/ROCK signaling
Show more Cellular/Molecular
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.